These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28584151)

  • 21. Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha.
    Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Hirose S; Murakami T; Yamamoto N; Mimura T; Kaneko Y
    Microbiol Immunol; 1997; 41(9):741-5. PubMed ID: 9343827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
    Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
    J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
    Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
    Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp.
    O'Keefe BR; Erim T; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Johnson DG; Buckheit RW; Halliday S; Boyd MR
    FEBS Lett; 1998 Jul; 431(1):85-90. PubMed ID: 9684871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.
    Tamamura H; Ishihara T; Otaka A; Murakami T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochim Biophys Acta; 1996 Nov; 1298(1):37-44. PubMed ID: 8948487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.
    Balzarini J; Van Laethem K; Daelemans D; Hatse S; Bugatti A; Rusnati M; Igarashi Y; Oki T; Schols D
    J Virol; 2007 Jan; 81(1):362-73. PubMed ID: 17050611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Phytopolyphenols for their gp120-CD4 Binding Inhibitory Properties by In Silico Molecular Modelling & In Vitro Cell Line Studies.
    Mirani A; Kundaikar H; Velhal S; Patel V; Bandivdekar A; Degani M; Patravale V
    Curr HIV Res; 2019; 17(2):102-113. PubMed ID: 31187713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
    Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
    PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
    Gu R; Westervelt P; Ratner L
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
    Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
    Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.
    Finnegan CM; Rawat SS; Cho EH; Guiffre DL; Lockett S; Merrill AH; Blumenthal R
    J Virol; 2007 May; 81(10):5294-304. PubMed ID: 17344303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.